ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1199 • 2012 ACR/ARHP Annual Meeting

    Proteases Produced by Porphyromonas Gingivalis Can Cleave and Citrullinate Substrates Found in the Joint and Oral Mucosa: Implications for Autoimmunity in Rheumatoid Arthritis

    Nidhi Sofat1, Saralili Robertson2 and Robin Wait3, 1Rheumatology, St. George's University of London, London, United Kingdom, 2Biomedical Sciences, St. George's University of London, London, United Kingdom, 3Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease characterised by inflammation followed by tissue rebuilding or fibrosis. Failure by the body to effectively regulate inflammation…
  • Abstract Number: 1200 • 2012 ACR/ARHP Annual Meeting

    Anti-Cyclic Citrullinated Peptide Antibodies in Idiopathic Pulmonary Fibrosis Are Not Citrulline-Specific: Implications for the Pathogenesis of Rheumatoid Arthritis

    Elena B. Lugli1, Muslima Chowdhury1, Peter J. Charles2, Michael G. Crooks3, Simon P. Hart3, Patrick Venables1 and Benjamin A. Fisher4, 1Kennedy Institute of Rheumatology, Oxford University, London, United Kingdom, 2Oxford University, Kennedy Institute of Rheumatology, Oxford, United Kingdom, 3Castle Hill Hospital, Hull York Medical School, Cottingham, United Kingdom, 4Rheumatology Research Group, University of Birmingham, Birmingham, United Kingdom

    Background/Purpose: The association of rheumatoid arthritis (RA) with smoking and silica exposure has led to the hypothesis that the lung is the site where RA autoimmunity…
  • Abstract Number: 1201 • 2012 ACR/ARHP Annual Meeting

    Anti-Citrullinated Protein Antibody Specific Fc Glycosylation Patterns in Arthralgia Patients

    Hans Ulrich Scherer1, Yoann Rombouts2, Ewoud Ewing3, Lotte van de Stadt4, Maurice H.J. Selman5, André M. Deelder3, Tom W.J. Huizinga2, Manfred Wuhrer5, Dirkjan van Schaardenburg6 and René E.M. Toes2, 1Rheumatology, Leiden University Medical Centre, Leiden, Netherlands, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Biomolecular Mass Spectrometry Unit, Department of Parasitology, Leiden University Medical Center, Leiden, Netherlands, 4Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, 5Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands, 6Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands

    Background/Purpose: Anti-citrullinated protein antibodies (ACPA) exhibit a specific, pro-inflammatory Fc glycosylation profile characterized by a low content of galactose and sialic acid residues. The absence…
  • Abstract Number: 1202 • 2012 ACR/ARHP Annual Meeting

    Antibodies Against Porphyromonas Gingivalis Correlate with Rheumatoid Arthritis-Specific Auto-Immunity in Arthralgia Patients

    M. J. de Smit1, L. A. van de Stadt2, J. Westra3, B. Doornbos-van der Meer3, K.M.J. Janssen4, A. Vissink5, A. J. van Winkelhoff6, E. Brouwer7 and Dirkjan van Schaardenburg8, 1Center for Dentistry and Oral Hygiene, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, 3Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 4Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 5Oral and Maxillofacial Surgery, University of Groningen, University Medical Center, Groningen, Netherlands, 6Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 7Rheumatology and Clinical Immunology, University of Groningen, University Medical Center, Groningen, Netherlands, 8Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands

    Background/Purpose: In the disease association between rheumatoid arthrtitis (RA) and periodontitis a potential role is suggested for the periodontal pathogen Porphyromonas gingivalis (PG). PG is…
  • Abstract Number: 1203 • 2012 ACR/ARHP Annual Meeting

    High Expression of Genes in the Toll-Like Receptor and Interferon Pathways Are Associated with Radiographic Damage in African-Americans with ACPA-Positive RA

    Maria I. Danila1, A. D. Steg2, Xiangqin Cui3, David Redden4, M. R. Johnson2, Richard J. Reynolds5, D. van der Heijde6, Doyt L. Conn7, Beth L. Jonas8, Leigh F. Callahan9, Larry W. Moreland10, P. K. Gregersen11 and S. Louis Bridges Jr.12, 1Med/Clinical Immun & Rheum, Univ of Alabama-Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, 3Biostatistics, University of Alabama at Birmingham, 4Biostatistics, University of Alabama at Birmingham, Birmingham, AL, 5Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 6Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 7Rheumatology, Emory Univ School of Medicine, Atlanta, GA, 8Thurston Arthritis Research Ct, University of North Carolina at Chapel Hill, Chapel Hill, NC, 9Thurston Arthritis Res Ctr, University of North Carolina, Chapel Hill, NC, 10Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 11Genomics and Human Genetics, Feinstein Institute Medical Research and North Shore-Long Island Jewish Health System, Manhasset, NY, 12Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: The clinical phenotype of rheumatoid arthritis (RA) ranges from mild joint inflammation to severe joint destruction, but molecular factors responsible for variability are incompletely…
  • Abstract Number: 1204 • 2012 ACR/ARHP Annual Meeting

    Porphyromonas Gingivalis Antibody Responses and Clinical Associations in Patients with Early Rheumatoid Arthritis

    Sheila L. Arvikar1, Klemen Strle2, Deborah S. Collier3, Mark C. Fisher1, Gail McHugh4, Toshihisa Kawai5, Alpdogan Kantarci6 and Allen C. Steere7, 1Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Boston, MA, 3Rheumatology, Massachusetts General Hospital, Boston, MA, 4Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, 5Forsyth Institute, Cambridge, MA, 6Forsyth Institute, Forsyth Institute, Cambridge, MA, 7Center for Immunolgy and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA

    Background/Purpose:  Three prior studies have demonstrated an increased frequency of antibody responses to P. gingivalis (Pg), a leading agent of periodontal disease (PD), in RA…
  • Abstract Number: 1205 • 2012 ACR/ARHP Annual Meeting

    Study of Association of CD40-CD154 Gene Polymorphisms with Disease Susceptibility and Cardiovascular Risk in Spanish Rheumatoid Arthritis Patients

    Mercedes García-Bermúdez1, Carlos González-Juanatey2, Alfonso Corrales3, Raquel López-Mejías4, Maria Teruel5, Jose A. Miranda-Filloy6, Santos Castañeda-Sanz7, Alejandro Balsa8, B. Fernández-Gutierrez9, Isidoro González-Álvaro10, Carmen Gómez-Vaquero11, R. Blanco Alonso12, Javier Llorca13, Javier Martin14 and Miguel Angel González-Gay4, 1Immunology and Cellular Biology, Instituto de Parasitologia y Biomedicina López-Neyra, IPBLN-CSIC, Granada, Spain, 2Cardiology Division, Hospital Lucus Augusti, Lugo, Spain, 3Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 4Rheumatology, Hospital Universitario Marqués de Valdecilla. IFIMAV, Santander, Spain, 5Immunology, Instituto de Parasitología y Biomedicina López-Neyra, IPBLN-CSIC, Granada, Spain, 6Rheumatology, Division of Rheumatology, Hospital Lucus Augusti, Lugo, Spain, 7Rheumatology, Hospital Universitario de La Princesa. Madrid. Spain, Madrid, Spain, 8Rheumatology, La Paz Hospital. IdiPaz, Madrid, Spain, 9Department of Rheumatology, Hospital Clinico San Carlos, Madrid, Spain, 10Servicio de Reumatología, Reumatología (Hospital Universitario de La Princesa), Madrid, Spain, 11Rheumatology Service, Hospital Universitari de Bellvitge - IDIBELL, Barcelona, Spain, 12Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Spain, 13Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), Santander, Spain, 14Immunology, Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN-CSIC), Granada, Spain

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increased cardiovascular (CV) mortality. Since CD40-CD154 binding has direct consequences on inflammation process initiation,…
  • Abstract Number: 1206 • 2012 ACR/ARHP Annual Meeting

    Gp96 Exacerbate the Inflammation of Rheumatoid Arthritis

    Qi Quan Huang1, Robert Birkett2, J.-P. Jin3 and Richard M. Pope4, 1Medicine/Rheumatology, Northwestern University, Chicago, IL, 2Division of Rheumatology, Department od Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Physiology, Wayne State University, Detroit, MI, 4Rheumatology, Northwestern University Feinberg school of Medicine, Chicago, IL

    Background/Purpose: The mechanisms that contribute to the persistent activation of macrophages in rheumatoid arthritis (RA) are incompletely understood.  Toll-like receptors (TLRs) have been implicated in…
  • Abstract Number: 1207 • 2012 ACR/ARHP Annual Meeting

    Impact of Anti Tumor Necrosis Factor-Alpha Therapy in Rheumatoid Arthritis On Osteoclast Activation and B Cells

    Ezinma Ezealah1, Jennifer Hossler1, Jamie Biear1, Christopher A. Cistrone1, Teresa Owen1, Nida Meednu1, Kelly Callahan1, Arumugam Palanichamy1, Ignacio Sanz2, Allen P. Anandarajah1, Ralf G. Thiele1, Darren Tabechian3, R. John Looney1 and Jennifer H. Anolik1, 1Medicine- Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 2Rheumatology, Emory University, Atlanta, GA, 3Allergy/Immun/Rheumatology, Univ of Rochester Schl of Med, Rochester, NY

    Background/Purpose:  Serum receptor activator of NFkB ligand (RANKL) and its natural decoy receptor, osteoprotegerin (OPG), play key roles in osteoclast activation. In a group of…
  • Abstract Number: 1208 • 2012 ACR/ARHP Annual Meeting

    Stable Synovial Fluid Phenotype for Anti Citrullinated-Protein Antibodies in Established Rheumatoid Arthritis

    Vijay Joshua1, Lena Israelsson2, Lars Klareskog3, Anca Catrina1 and Vivianne Malmström4, 1Department of Medicine, Rheumatology unit, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden, 2Department of Medicine, Karolinska Institute, Stockholm, Sweden, 3Department of Medicine, Rheumatology Unit, Karolinska Institute, Stockholm, Sweden, 4Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Presence of anti citrullinated-protein antibodies (ACPA) in the peripheral blood of patients with rheumatoid arthritis is a validated disease biomarker. We have previously shown…
  • Abstract Number: 1209 • 2012 ACR/ARHP Annual Meeting

    Functional Role of Chondrogenic Progenitor Cells in Rheumatoid Arthritis

    Sabine Blaschke1, Sandra Trautmann1, Alexander W. Beham2, Burkhard Mai3, Sebastian Koelling1, Caroline Breysach4, Gabriele Wolf1, Gerhard A. Mueller1 and Nicolai Miosge5, 1Nephrology & Rheumatology, University Medical Center Goettingen, Goettingen, Germany, 2Department of Surgery, Germany, 3Vitos Orthopaedic Clinic Kassel, Kassel, Germany, 4Department of Surgery, Goettingen, Germany, 5Dept. of Prosthodontics, Goettingen, Germany

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory joint disease of still unknown etiology leading to progressive cartilage and bone destruction. Proinflammatory cytokines, immunoregulatory cells…
  • Abstract Number: 1210 • 2012 ACR/ARHP Annual Meeting

    Effect of HLA-DRB1*0901 Suggest Distinctive Mechanisms of Rheumatoid Arthritis Susceptibility

    So-Young Bang1, Hye-Soon Lee2, Kyung Wha Lee3 and Sang-Cheol Bae4, 1Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 2Department of Rheumatology, Hanyang University Guri Hospital, Guri, South Korea, 3Hallym Institute for Genome Application,Hallym University Sacred Heart Hospital, Anyang, South Korea, 4Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea

    Background/Purpose: Although HLA-DRB1 shared epitope (SE) alleles and DRB1*0901 have repeatedly been shown to be associated with RA susceptibility, the effect of each allele on…
  • Abstract Number: 1211 • 2012 ACR/ARHP Annual Meeting

    ANTI-Cyclic Citrullinated Protein Antibodies Induce Inflammation and Oxidative Stress in WHITE Blood CELLS of Rheumatoid Arthritis Patients

    Chary Lopez-Pedrera1, Carlos Perez-Sanchez1, Patricia Ruiz-Limon1, Mª Angeles Aguirre2, Rosario M. Carretero-Prieto1, Antonio Rodriguez-Ariza3, Nuria Barbarroja1, Pilar Font1, Francisco Martinez2, Inmaculada Gomez-Gracia2, Mª Jose Cuadrado4 and Eduardo Collantes-Estevez2, 1Rheumatology Unit, IMIBIC-Reina Sofia University Hospital, Cordoba, Spain, 2Rheumatology, IMIBIC-Reina Sofia Hospital, Cordoba, Spain, 3Oncology Service and Research Unit, IMIBIC-Reina Sofia Hospital, Cordoba, Spain, 4Lupus Research Unit, The Rayne Institute, London, United Kingdom

    Background/Purpose: Anti-cyclic citrulinated protein antibodies (anti-CCP) are the most specific autoantibody markers in rheumatoid arthritis (RA) patients. However no previous studies have evaluated their role…
  • Abstract Number: 1212 • 2012 ACR/ARHP Annual Meeting

    Elevated Fecal Secretory Immunoglobulin A, Anti-Cyclic Citrullinated Peptide Antibodies, and Cytokine Levels in Rheumatoid Arthritis Patients

    Sam Dalvi1, Jose U. Scher*1, Mukundan Attur2, Jyoti Patel3 and Steven B. Abramson4, 1Rheumatology, NYU Hospital for Joint Diseases, New York, NY, 2Division of Rheumatology, Department of Medicine, NYU Hospital for Joint Diseases, New York, NY, 3Rheumatology, NYU Langone Medical Center, New York, NY, 4Dept of Rheumatology/Medicine, NYU Langone Medical Center, New York, NY

    Background/Purpose: Rheumatoid arthritis (RA) is a complex autoimmune disease with genetic and environmental contributions. There has been increasing interest in the microbiome and its potential…
  • Abstract Number: 1213 • 2012 ACR/ARHP Annual Meeting

    The Serum Cytokine Profile of Interstitial Lung Disease in Rheumatoid Arthritis

    Jose Felix Restrepo1, Inmaculada del Rincon2, Roy Haas3, Daniel F. Battafarano4 and Agustin Escalante5, 1Rheumatology, University of Texas Health Science Center, San Antonio, TX, 2Rheumatology, University Of Texas, Health Science Center, San Antonio, TX, 3Rheumatology, TX, 4Medicine / MCHE-MDR, Brooke Army Medical Ctr, San Antonio, TX, 5Dept. of Medicine-Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX

    Background/Purpose: Interstitial lung disease (ILD) is associated with significant morbidity and mortality in rheumatoid arthritis (RA). There are currently no proven biomarkers for ILD in…
  • « Previous Page
  • 1
  • …
  • 2521
  • 2522
  • 2523
  • 2524
  • 2525
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology